Visionary Wealth Advisors Has $9.63 Million Stock Holdings in Ultralife Co. (NASDAQ:ULBI)

Visionary Wealth Advisors lifted its stake in Ultralife Co. (NASDAQ:ULBI - Free Report) by 17.1% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 1,292,836 shares of the technology company's stock after acquiring an additional 188,384 shares during the period. Visionary Wealth Advisors owned 7.77% of Ultralife worth $9,632,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors also recently made changes to their positions in ULBI. IFP Advisors Inc bought a new stake in shares of Ultralife in the 4th quarter worth approximately $85,000. Bank of America Corp DE raised its holdings in shares of Ultralife by 30.7% in the 4th quarter. Bank of America Corp DE now owns 12,067 shares of the technology company's stock worth $90,000 after purchasing an additional 2,836 shares in the last quarter. Barclays PLC raised its holdings in shares of Ultralife by 13.7% in the 4th quarter. Barclays PLC now owns 15,233 shares of the technology company's stock worth $113,000 after purchasing an additional 1,838 shares in the last quarter. LSV Asset Management bought a new stake in shares of Ultralife in the 4th quarter worth approximately $145,000. Finally, Nuveen Asset Management LLC raised its holdings in shares of Ultralife by 59.1% in the 4th quarter. Nuveen Asset Management LLC now owns 21,647 shares of the technology company's stock worth $161,000 after purchasing an additional 8,037 shares in the last quarter. 30.68% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Separately, Wall Street Zen upgraded shares of Ultralife from a "hold" rating to a "buy" rating in a report on Thursday.

Ultralife Trading Down 1.3%

Shares of ULBI stock traded down $0.07 during trading hours on Friday, reaching $5.46. 60,897 shares of the stock traded hands, compared to its average volume of 69,589. Ultralife Co. has a 1-year low of $4.07 and a 1-year high of $12.40. The business has a fifty day moving average price of $4.92 and a 200 day moving average price of $6.49. The company has a quick ratio of 1.62, a current ratio of 3.30 and a debt-to-equity ratio of 0.04. The firm has a market capitalization of $90.82 million, a PE ratio of 9.93 and a beta of 0.77.

Ultralife (NASDAQ:ULBI - Get Free Report) last released its quarterly earnings results on Friday, May 9th. The technology company reported $0.13 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.15 by ($0.02). Ultralife had a net margin of 5.44% and a return on equity of 7.92%. The firm had revenue of $50.75 million for the quarter, compared to analyst estimates of $54.50 million. During the same quarter in the prior year, the firm earned $0.21 EPS.

Insider Activity

In other news, Director Thomas Louis Saeli purchased 5,000 shares of the business's stock in a transaction dated Wednesday, May 14th. The shares were acquired at an average price of $5.44 per share, for a total transaction of $27,200.00. Following the completion of the acquisition, the director now directly owns 85,000 shares of the company's stock, valued at $462,400. The trade was a 6.25% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Also, Director Bradford T. Whitmore acquired 16,063 shares of the company's stock in a transaction on Wednesday, May 14th. The stock was bought at an average price of $5.47 per share, for a total transaction of $87,864.61. Following the purchase, the director now owns 1,045,947 shares in the company, valued at approximately $5,721,330.09. This trade represents a 1.56% increase in their position. The disclosure for this purchase can be found here. Insiders have bought 35,160 shares of company stock worth $191,543 over the last 90 days. 39.90% of the stock is owned by company insiders.

Ultralife Company Profile

Ultralife Corporation, together with its subsidiaries, designs, manufactures, installs, and maintains power, and communication and electronics systems worldwide. The company operates in two segments, Battery & Energy Products and Communications Systems. The Battery & Energy Products segment offers lithium 9-volt, cylindrical, thin lithium manganese dioxide, rechargeable, and other non-rechargeable batteries; lithium-ion cells, multi-kilowatt module lithium-ion battery systems, and uninterruptable power supplies; and rugged military and commercial battery charging systems and accessories, including smart chargers, multi-bay charging systems, and various cables.